Latticework Capital Management has announced its acquisition of Catalina Research Institute (CRI).
CRI, based in Montclair, Calif., is a multidisciplinary clinical trials facility. Founded in 1997, the company specializes in the conduct of phase II through phase IV pharmaceutical drug studies.
Latticework, based in Dallas, makes control equity investments in the lower middle